The Evidence Base for Diabetes Care

2. Auflage 2010
ISBN: 978-0-470-03274-9
Verlag: Turner Publishing Company

Buch, Englisch, 509 Seiten, Format (B × H): 228 mm x 288 mm, Gewicht: 1572 g

Now in its second edition, The Evidence Base for Diabetes Care has been fully revised and updated to incorporate new evidence from clinical trials. The aim of the book remains the same - to provide treatment recommendations based on the latest research and ensure patients with diabetes receive the best possible care.

Designed to be user-friendly, the evidence is displayed in clear tables with accompanying critiques including grading of evidence where appropriate. As well as summarizing the current evidence available for diabetes prevention and care, the contributors highlight areas where evidence is lacking and where studies are underway.

This book is an invaluable source of evidence-based information distilled into guidance for clinical practice.

Autoren/Hrsg.

Herman, William

Kinmonth, Ann Louise

Wareham, Nick

Williams, Rhys

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Evidenzbasierte Medizin (EbM)
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Stoffwechselstörungen
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Diabetologie

Inhaltsverzeichnis

List of Contributors.

1 The evidence base for diabetes care (William H. Herman, Ann Louise Kinmonth, Nicholas J. Wareham, Rhys Williams).

Part 1: Evidence-based definition and classification.

2 Classification of diabetes (Maximilian de Courten).

3 Commentary on the classification and diagnosis of diabetes (Stephen O'Rahilly, Nicholas J. Wareham).

Part 2: Primary and primordial prevention and early detection.

4 Prevention of type 1 diabetes (Jay S. Skyler).

5 Prevention of type 2 and gestational diabetes (Richard F. Hamman, Dana Dabelea).

6 The evidence to screen for type 2 diabetes (Michael M. Engelgau, K.M. Venkat Narayan).

Part 3: Prevention of complications.

7 The effectiveness of interventions aimed at weight loss and other effects of diet and physical activity in achieving control of diabetes and preventing its complications (Nita Gandhi Forouhi, Nicholas J. Wareham).

8 What is the evidence that changing tobacco use reduces the incidence of diabetic complications? (Deborah L. Wingard, Elizabeth Barrett-Connor, Nicole M. Wedick).

9 Does intensive glycaemic management reduce morbidity and mortality in type 1 diabetes? (William H. Herman).

10 Does intensive glycaemic management reduce morbidity and mortality in type 2 diabetes? (Amanda I. Adler).

11 Glycaemic control and other interventions in the treatment of gestational diabetes (David R. McCance).

12 Antihypertensive therapy to prevent the cardiovascular complications of diabetes mellitus (Tonya L. Corbin, Alan B. Weder).

13 Does treating hyperlipidaemia with medication prevent complications? (Helen M. Colhoun).

14 Other cardiovascular risk factors (Stephen Thomas, GianCarlo Viberti).

15 Prevention of the consequences of diabetes - a commentary (Hertzel C. Gerstein).

Part 4: Treatment of established complications.

16 Treatment of diabetic retinopathy (Ayad Al-Bemani, Roy Taylor).

17 Prevention and treatment of diabetic nephropathy: the role of blood pressure lowering (Carl Erik Mogensen).

18 Treatment of established complications: periodontal disease (George W. Taylor, Wenche S. Borgnakke).

19 Treatment of diabetic neuropathy (Rodica Pop-Busui, Zachary Simmons, Eva L. Feldman).

20 Treatment of erectile dysfunction (David E. Price, Geoffrey Hackett).

21 Cardiac complications and management (Anthony S. Wierzbicki, Simon R. Redwood).

22 The treatment of established complications: cerebrovascular disease (Devin Brown, Susan L. Hickenbottom).

23 The management of peripheral arterial disease in patients with type 2 diabetes (Sydney A. Westphal, Pasquale J. Palumbo).

24 Epidemiology of foot ulcers and amputations in people with diabetes: evidence for prevention (Gayle E. Reiber, William R. Ledoux).

Part 5: Self-management, healthcare organization and public policy.

25 What is the evidence that increasing engagement of individuals in self-management improves the processes and outcomes of care? (Debra L. Roter, Ann Louise Kinmonth).

26 Delivering care to the population (Rhys Williams, Ann John, Ambady Ramachandran, Chamukuttan Snehalatha).

27 Cost-effectiveness of interventions for the prevention and control of diabetes (Rui Li, Ping Zhang).

28 The role of public policy (Julia Critchley, Nigel Unwin).

Index.

Über Autor(innen)

William Herman

Professor Herman is an internationally recognized researcher, educator, and clinician in the prevention and treatment of diabetes. He is currently the Director of the Michigan Diabetes Research and Training Center. He has given over 125 invited lectures around the world, and has published eight books, 26 book chapters and almost 150 articles in peer-reviewed journals. He was associate editor for the journals Clinical Diabetes and Diabetes Care.

Professor Herman is the recipient of the American Diabetes Association's Kelly West Award for Outstanding Achievement in Epidemiology.

Rhys Williams

Professor Rhys Williams is Professor of Clinical Epidemiology at the University of Wales, Swansea. He is Vice-President of the International Diabetes Federation (IDF) and Chair of the IDF Task Force on Diabetes Awareness. He is also Chair of Diabetes UK's Wales Advisory Council. His main research interests relate to diabetes and the metabolic syndrome, especially their epidemiology, health services research and economics.

Ann Louise Kinmonth

Professor Kinmonth is the Foundation Professor of General Practice at the University of Cambridge.

She has contributed through research to the management of diabetes and prevention of cardiovascular disease in general practice and is also interested in the impact of genetics on general medical practice.

Nick Wareham

Professor Wareham is an Honorary Consultant at Addenbrooke's Hospital, Cambridge.

He is Director of the MRC Epidemiology Unit and co-Director of the Institute of Metabolic Science. His principal research interests are the aetiology and prevention of obesity and diabetes. He also leads the Aetiology of Diabetes Programme and is the Clinical Lead for the Eastern England Diabetes Local Research Network.